Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2212-2016

DIAMOND-FLEX CIRCULAR RETRACTOR, ANGLED, 40MM 5MM, Product Code 89-6114, Lot Code(s): 878971; 879366; 879404, and Date Code: C16. Designed to retract or elevate organs and tissue to provide better visualization access.

Publicado el 3 de agosto de 2016 · Inicio del retiro: 1 de julio de 2016

Resumen

FDA registra el retiro Z-2212-2016 de dispositivos médicos de Clase I, publicado el 3 de agosto de 2016 e iniciado el 1 de julio de 2016. Empresa responsable: Carefusion 2200 Inc; Estado: Finalizado; Cantidad reportada: 10; Lote: Product Code 89-6114, Lot Code(s): 878971; 879366; 879404, and Date Code: C16. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

BD, formerly CareFusion, has identified a potential risk associated with a weld failure which could result in the wire protruding thru the tip of the instrument when articulated. If this failure were to occur while in use in a procedure it has the potential to damages tissue or organs

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Carefusion 2200 Inc
Distribuidor
Worldwide Distribution - US, including the states of WA and MD; and, the country of Japan.
Lote
Product Code 89-6114, Lot Code(s): 878971; 879366; 879404, and Date Code: C16
Clasificación de riesgo
Class I
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿DIAMOND-FLEX CIRCULAR RETRACTOR, ANGLED, 40MM 5MM, Product Code 89-6114, Lot Code(s): 878971; 879366; 879404, and Date Code: C16. Designed to retract or elevate organs and tissue to provide better visualization access. fue retirado del mercado?

Sí. FDA publicó el retiro Z-2212-2016 el 3 de agosto de 2016. Peligro reportado: BD, formerly CareFusion, has identified a potential risk associated with a weld failure which could result in the wire protruding thru the tip of the instrument when articulated. If this failure were to occur while in use in a procedure it has the potential to damages tissue or organs

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter